Future Health Featured Articles

Future Health articles are available to CHR donors. To become a donor or to subscribe to the quarterly see Support/Subscribe.

  • According to a study led by a team at the Research Institute of the McGill University Health Centre (RI-MUHC), medication used to treat bone deterioration in post-menopausal women may slow the spread (metastasis) of breast cancer to the skeleton. This study, published in the Journal of the National Cancer Institute (JNCI), is among the first to link bisphosphonate, a common osteoporosis...

  • The past year marks one of the most difficult in the history of CHR, as the organization has coped with diminished financial resources and the ongoing challenge of reshaping its administration to preserve institutional goals.
    With regard to finances, there were increased costs associated with the upgrading and maintenance of the Web site, as well as legal fees associated with obtaining a...

  • Marc Bomhof would like to amend the old saying, “You are what you eat”, to be more accurate. Perhaps something like: “You are what you and your gut microbiota eat”.

    “About 100 trillion bacteria live in our digestive tract,” explains Bomhof. “We have about 10 trillion human cells versus 100 trillion bacterial cells and so we’re essentially 10% human and 90% bacteria. These things...

  • When it comes to heart disease, Dr. Ross Feldman says women are often in the dark.

    When it comes to heart disease, Dr. Ross Feldman says women are often in the dark. Historically, it was thought heart disease was a men’sonly disease; however, data has shown that postmenopausal women are just as likely as men to get heart disease and are less likely to be adequately diagnosed and treated...

  • The 2014 Annual General Meeting of Canadians for Health Research will be held at 11:00 a.m. on Friday, November 14, 2014 at 3647 Peel Street, Montreal, Quebec

  • A study published in Nature Neuroscience by Yves De Koninck and Robert Bonin, two researchers from the Faculty of Medicine at Université Laval and Institut universitaire en santé mentale de Québec (IUSMQ), reveals that it is possible to relieve pain hypersensitivity by using a new method that involves rekindling pain, so that it can subsequently be erased. This discovery could lead to...

  • The discovery of mutations in a single gene in multiple cases of small cell carcinoma of the ovary, hypercalcaemic type (SCCOHT) – the most common undifferentiated ovarian cancer to strike women under 40 – is a huge breakthrough. This finding of a team of researchers, led by Dr. William Foulkes at the Lady Davis Institute (LDI) at Montreal’s Jewish General Hospital (JGH) are published in ...

  • A new study from researchers at the University of Ottawa Heart Institute (UOHI), published in Cell Reports, sheds light on a mysterious gene that likely influences cardiovascular health.

    After five years, UOHI researchers now know how one genetic variant works and suspect that it contributes to the development of heart disease through processes that promote chronic inflammation...

  • Cancer is the leading cause of death in Canada. It is responsible for about 30% of all deaths, according to the Canadian Cancer Society. Despite the urgent need for new and effective drugs, it remains extremely difficult to develop anti-cancer therapies in a timely way. Researchers in Ottawa looked at how to leverage current experimental therapies, in different combinations, to speed the fight...

Pages